FDA Draft Guidance on Generic-Delaying Citizen Petitions a 'Warning Shot' to Industry, Lawyer Says
October 11, 2018
Alaric DeArment
MedCity News
Axinn partner Chad Landmon was quoted in the MedCity News article, "FDA Draft Guidance on Generic-Delaying Citizen Petitions a 'Warning Shot' to Industry, Lawyer Says."
Click here to access the article.